GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the human sialidase NEU2 Q116E mutant in complex with dana inhibitor

Analyse Crystal structure of the human sialidase NEU2 Q116E mutant in complex with dana… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2F29
Type
protein
Length
740 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Sialidase 2
EC
3.2.1.18
UniProt
Q9Y3R4
Ligands
DAN
Pockets
8 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSialidase 2 (EC 3.2.1.18)protein3706% helix, 51% strandQ9Y3R4

Ligands and binding sites

  • DAN · 2-deoxy-2,3-dehydro-N-acetyl-neuraminic acid · ligand · 2 copies · chains A, B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12170.710.8739empty
23200.640.8027empty
33080.630.8029empty
42030.590.8134DAN, EPE
51720.590.8231DAN

Interfaces

1 interface between chains.

  • A–B · 1008 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 2F29 · Crystal Structure of the Human Sialidase Neu2 Q116E Mutant in Complex with DANA Inhibitor · the same entry in another collection · chain B against B, TM-score 1.00
  • Q9Y3R4 · AlphaFold monomer V2.0 prediction for sialidase-2 (Q9Y3R4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.